An article by Lin Li and Matthew Grady titled “Turning Foreign-Filed Patent Applications into Strong US Patents: Key Strategies and Considerations” was published in Intellectual Property & Technol...
In today’s competitive and innovation-driven economy, protecting intellectual property (IP) is no longer just about securing utility patents. A well-rounded IP strategy that incorporates multiple form...
An article authored by Michele Moresco titled “Build an Effective IP Strategy in Photonics” was published in Laser Focus World. Photonics is rapidly transforming from a primarily academic discipline i...
A column authored by Jason Balich titled “Broadening Your (Patent) Protection” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In this arti...
Spring has arrived, and in addition to cleaning, it’s a good time to reassess how your company is handling its trade secrets. Far from being static, trade secret innovations, processes, and data evolv...
We are pleased to spotlight Associate Elizabeth Simonik Mulski this month! Liz works in the Biotechnology group in our Boston office.
John Welch co-authored the January-February 2025 edition of The Trademark Reporter, The Law Journal of The International Trademark Association (INTA). Titled “United States Annual Review: The Seventy-...
We are pleased to spotlight Patent Paralegal Nyasha Mombeshora this month! Nyasha works in the Biotechnology Practice in our Boston office.
From the pages of The New York Times to the…general counsel’s office of The New York Times, AI copyright litigation is all the rage. Possible questions include the philosophical—e.g. “Could an AI agen...
In Lynk Labs, Inc., v. Samsung Electronics Co., Ltd., the Federal Circuit reinforced that patent applications may serve as prior art in IPR proceedings as of their filing date—even where those applica...
A column authored by Jason Balich titled “Protecting Trade Secrets” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In this article, Jason ...
From potential legal challenges to Chinese biopharma supply chains, Europe’s new Unified Patent Court (UPC), landmark decisions in life sciences, pharma’s Orange Book listings, design patent rejection...